Erratum to: Personalized anti-thrombotic management of patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1 - a statement of the ESC Working Group on Cardiovascular Pharmacotherapy and ESC Council on Stroke
- PMID: 34269377
- DOI: 10.1093/eurheartj/ehab455
Erratum to: Personalized anti-thrombotic management of patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1 - a statement of the ESC Working Group on Cardiovascular Pharmacotherapy and ESC Council on Stroke
Erratum for
-
Personalized anti-thrombotic management of patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1 — a statement of the ESC Working Group on Cardiovascular Pharmacotherapy and ESC Council on Stroke [corrected].Eur Heart J. 2021 Feb 1;42(5):541-543. doi: 10.1093/eurheartj/ehaa1081. Eur Heart J. 2021. PMID: 33496325 No abstract available.
References
Publication types
LinkOut - more resources
Full Text Sources
